Role of integrin-linked kinaae in neurite outgrowth and axon guidance on neuronal repair
Role of integrin-linked kinaae in neurite outgrowth and axon guidance on neuronal repair
批准号:
14560242
负责人:
ISHII Toshiaki
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mouse N1E-115 cells grown on a laminin matrix exhibit neurite outgrowth in response to serum deprivation. Treatment of cells with an antibody against β1 integrin inhibits neurite outgrowth. Thus, β1 integrin is involved in the neuritogenesis of N1E-115 cells on a laminin matrix. Integrin-linked kinase (ILK), a recently identified cytoplasmic serine/threonine protein kinase that binds to the cytoplasmic domain of β1 integrin, has an important role in transmembrane signal transduction via integrins. We report that ILK is expressed in N1E-115 cells, the expression levels of which are constant under both normal and differentiating conditions. A stable transfection of a kinase-deficient mutant of ILK (DN-ILK) results in inhibition of neurite outgrowth in serum-starved N1E-115 cells grown on laminin. On the other hand, a transient expression of wild-type ILK stimulated neurite outgrowth. The ILK activity in the parental cells was transiently activated after seeding on the laminin matrix, whe … More reas that in the DN-ILK transfected cells was not. These results suggest that transient activation of ILK is required for neurite outgrowth in serum-starved N1E-115 cells on laminin. Under the same conditions, p38 mitogen-activated protein (MAP) kinase, but neither MAP kinase/extracellular signal-regulated kinases kinase (MEK) nor extracellular signal-regulated kinases (ERK), was transiently activated after N1E-115 cell attachment to laminin, but not in the DN-ILK expressed cells. The tune course of p38 MAP kinase activation was very similar to that of ILK activation. Furthermore, a p38 MAP kinase inhibitor, SB203580, significantly blocked neurite outgrowth. Thus, activation of p38 MAP kinase is involved in ILK-mediated signal transduction leading to integrin-dependent neurite outgrowth in N1E-115 cells. Moreover, ILK also controls tau phosphorylation via regulation of glycogen synthase kinase-3β (GSK-3β) activity in N1E-115 cells. Stable transfection of DN-ILK resulted in aberrant tau phosphorylation in N1E-115 cells at sites recognized by the Tau-1 antibody, which are identical to some of the phosphorylation sites in paired helical filaments, (PHF)-tau, in brains of patients with Alzheimer's disease. The tau phosphorylation levels in the DN-ILK-expressing cells are constant under normal and differentiating conditions. On the other hand, aberrant tau phosphorylation was not observed in the parental control cells. ILK inactivation resulted in an increase in the active form but a decrease in the inactive form of GSK-3β, which is a candidate kinase involved in PHF-tau formation. Moreover, inhibition of GSK-3β with lithium prevented aberrant tau phosphorylation in the DN-ILK-expressing cells. These results suggest that ILK inactivation results in aberrant tau phosphorylation via sustained activation of GSK-3β in N1E-115 Cells. ILK directly phosphorylates GSK-3β and inhibits its activity. Therefore, endogenous ILK protects against GSK-3β-induced aberrant tau phosphorylation via inhibition of GSK-3β activity in N1E-115 cells. Less
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ishii, T. et al.: "Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3β in N1E-115 neuroblastoma cells"J.Biol.Chem.. 278. 26970-26975 (2003)
Ishii, T. 等人:“整合素连接激酶的失活通过 N1E-115 神经母细胞瘤细胞中糖原合酶激酶 3β 的持续激活诱导异常 tau 磷酸化” J.Biol.Chem.. 278. 26970-26975 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toshiaki Ishii: "Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3βin N1E-115 neuroblastoma cells."J.Biol.Chem.. 278. 26970-26975 (2003)
Toshiaki Ishii:“整合素连接激酶的失活通过 N1E-115 神经母细胞瘤细胞中糖原合酶激酶 3β 的持续激活诱导异常 tau 磷酸化。”J.Biol.Chem.. 278. 26970-26975 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishii, T.et al.: "Integrin-linked kinase controls neurite outgrowth in N1E-115 neuroblastoma cells"J.Biol.Chem.. 276・46. 42994-43003 (2001)
Ishii, T. 等:“整合素连接激酶控制 N1E-115 神经母细胞瘤细胞中的神经突生长”J.Biol.Chem.. 276・46 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishii, T. et al.: "Integrin-linked kinase controls neurite outgrowth in N1E-115 neuroblastoma cells"J.Biol.Chem.. 276. 42994-43003 (2001)
Ishii, T. 等人:“整合素连接激酶控制 N1E-115 神经母细胞瘤细胞中的神经突生长”J.Biol.Chem.. 276. 42994-43003 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toshiaki Ishii: "Integrin-linked kinase controls neurite outgrowth in N1E-115 neuroblastoma cells."J.Biol.Chem.. 276. 42994-43003 (2001)
Toshiaki Ishii:“整合素连接激酶控制 N1E-115 神经母细胞瘤细胞中的神经突生长。”J.Biol.Chem.. 276. 42994-43003 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
Attempt to develop animal model for the formation of paired helical filaments in the brains of Alzheimer's disease patients via sustained inactivation of integrin-linked kinase in mouse brain.
-
批准号:16380195
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.92万
-
财政年份:2004
-
负责人:ISHII Toshiaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
血管衰老通过lumican-integrinα2β1通路诱导NVU调控认知障碍的分子机制及干预靶点研究
-
批准号:JCZRLH202602095
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
β1-integrin介导的Warburg效应在TAM耐药乳腺癌中的作用及机制
-
批准号:JCZRLH202600554
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
睡眠剥夺经TNN/Integrin α8β1轴调控巨噬细胞极化促动脉粥样硬化的作用及机制研究
-
批准号:2025JJ60778
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:高嘉慧
-
依托单位:
维生素D受体通过抑制Mucin-1/β1-integrin信号通路调节肠道衰老的相关机制研究
-
批准号:MS25H030029
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:余梦丽
-
依托单位:
Integrinβ7阳性肥大细胞诱导免疫抑制微环境促进胰腺癌进展机制和干预策略研究
-
批准号:QN25H030033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吴将超
-
依托单位:
低强度脉冲超声波通过调控integrin β1/ FAK/ MAPKs信号轴诱导巨噬细胞自噬治疗糖尿病足的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郭恩琪
-
依托单位:
Osteopontin-Integrin-TAM-M2轴介导泌乳素细胞腺瘤耐药及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:汤浩
-
依托单位:
SMYD5 上调 EZH2-integrin β 1 通路促进三阴乳腺癌骨转
移的作用机制及其临床意义
-
批准号:2024JJ6590
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:丁诗容
-
依托单位:
Fndc5/irisin调控Integrin信号通路在乳腺癌溶骨性骨转移中的作用及
机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘扬
-
依托单位:
丝素蛋白膜拓扑结构通过Integrin-Yap通路诱导BMSCs成软骨分化促
软骨修复的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王鑫
-
依托单位: